| Company Name | Date of De-Listing | Effect Date | Reason |
|---|---|---|---|
| Gupta Synthetics | 25-Feb-2025 | 28-Feb-2025 | Trading Members of the Exchange are hereby informed that the undermentioned 04 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with effect from February 28, 2025, pursuant to order of the Delisting Committee of the Exchange in terms of Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 / 2021 ("Regulations"). Scrip Code 514116 Company Name Gupta Synthetics Ltd.* * These companies would be delisted in terms of Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009. Further, these companies are under Liquidation, hence consequences of compulsory delisting will not apply to these companies in terms of Public Notice dated November 30, 2017, issued by the Exchange. Consequences of compulsory delisting. 1. As per SEBI (Delisting of Equity Shares), Regulations, 2021: - · The securities of the companies would cease to be listed and therefore not be available for trading on the platform of the Exchange. In terms of Regulation 34 (1) of SEBI (Delisting of Equity Shares), Regulations, 2021, the delisted company, its whole-time directors, person(s) responsible for ensuring compliance with the securities laws, promoters, and companies which are promoted by any of them shall not directly or indirectly access the securities market or seek listing of any equity shares or act as an intermediary for a period of 10 (ten) years from the date of delisting. · Promoters of these delisted companies would be required to purchase the shares from the public shareholders as per the fair value determined by the independent valuer appointed by the Exchange, as mentioned in the Public Notice to be issued shortly. · Also, as per provisions of Regulation 34(2) of the SEBI (Delisting of Equity Shares), Regulations, 2021, in case of companies whose fair value is positive - a. such a company and the depositories shall not effect transfer, by way of sale, pledge, etc., of any of the equity shares held by the promoters / promoter group and the corporate benefits like dividend, rights, bonus shares, split, etc. shall be frozen for all the equity shares held by the promoters / promoter group, till the promoters of such company provide an exit option to the public shareholders in compliance with sub-regulation (4) of regulation 33 of these regulations, as certified by the relevant recognized stock exchange; b. the promoters, whole-time directors and person(s) responsible for ensuring compliance with the securities laws, of the compulsorily delisted company shall also not be eligible to become directors of any listed company till the exit option as mentioned in clause (a) is provided. 3. Further, these companies would be moved to the Dissemination Board of the Exchange. In case the Trading Members require any clarification, they may email on id bse.delistscn@bseindia.com. |
| Jaypee Infratech | 14-Feb-2025 | 21-Feb-2025 | Trading Members of the Exchange are hereby informed that pursuant to order by the Hon'ble National Company Law Tribunal, Delhi Bench, dated March 07, 2023, Jaypee Infratech Ltd ("the Company") applied for delisting of its equity shares. The Company has confirmed that it has complied with the requirements of NCLT order dated March 07, 2023 for delisting. Further the above scrip will be delisted from the Exchange records w.e.f. Friday, February 21, 2025. Trading Members of the Exchange are requested to take note of the above. |
| Reliance Capital | 06-Feb-2025 | 13-Feb-2025 | Trading Members of the Exchange are hereby informed that pursuant to order by the Hon'ble National Company Law Tribunal, Mumbai Bench, dated February 27, 2024, Reliance Capital Ltd. ("the Company") applied for delisting of its equity shares. The Company has confirmed that it has complied with the requirements of NCLT order dated February 27, 2024 for delisting. Further the above scrip will be delisted from the Exchange records w.e.f. Thursday, February 13, 2025. Trading Members of the Exchange are requested to take note of the above. |
| Parenteral Drugs | 01-Feb-2025 | 01-Feb-2025 | Parenteral Drugs (India) Limited vide its announcement dated January 23, 2024, has informed the Exchange that Hon'ble NCLT, Mumbai Bench, has ordered that the shares of the Company shall automatically stand delisted from all the Stock Exchanges without any cost or liability and the stock exchange shall immediately do the needful to do the delisting. Further, it may be noted that trading in the shares of the Company is under suspension on account of non-compliance with Regulation 31 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, therefore trading in the shares of the company shall remain suspended till further notice. Scrip Code 524689 Name of the Company Parenteral Drugs (India) Limited |
| Ador Fontech | 27-Jan-2025 | 28-Jan-2025 | Trading Members of the Exchange are hereby informed that the under mentioned Companies which have been suspended due to Record Date fixed for the Corporate Action of Amalgamation shall be delisted with effect from 28th January, 2025 :- Scrip Code to Delisted 530431 ISIN No. to be Delisted INE853A01022 Company Name to be Delisted Ador Fontech Ltd Reason AMALGAMATION/ MERGED with Ador Welding Ltd. |